Foghorn Therapeutics Inc — Balance Sheet (NASDAQ:FHTX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Total assets 255.59 M519.77 M404.88 M285.92 M283.98 M198.1 M Total liabilities 109.41 M422.9 M404.77 M363.11 M329.51 M306.6 M Total equity 146.19 M96.87 M112 K-77.19 M-45.53 M-108.5 M Total liabilities & shareholders' equities 255.59 M519.77 M404.88 M285.92 M283.98 M198.1 M Total debt 19.65 M0———— Net debt -10.8 M-42.8 M————

Haberler

Foghorn, AACR toplantısında kanser verileri sunacak

Strength Seen in Dianthus Therapeutics, Inc. (DNTH): Can Its 5.6% Jump Turn into More Strength?

Citizens, Foghorn Therapeutics hissesi için hedef fiyatını korudu

Citizens reiterates Foghorn Therapeutics stock rating on pipeline progress

Jefferies, Foghorn Therapeutics hissesi için tavsiyesini korudu

Jefferies reiterates Foghorn Therapeutics stock rating on pipeline data

Stifel, Foghorn Therapeutics hissesi için al önerisini yineledi

Stifel reiterates Foghorn Therapeutics stock rating at buy

Foghorn kazancı $0,02 ile beklentilere göre daha kötü, kâr ise beklentilere göre düşük

Foghorn earnings missed by $0.02, revenue fell short of estimates

Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Beats Revenue Estimates

Foghorn Therapeutics nakit pozisyonu 158,9 milyon dolar